In a remarkable display of market confidence, shares of CorVel Corp (CRVL) have surged to an all-time high, reaching a price level of $368.93. This milestone underscores a period of significant growth for the healthcare management company, which has seen its stock value skyrocket by an impressive 72.97% over the past year. Investors have been buoyed by CorVel's consistent performance and strategic initiatives, propelling the stock to new heights and setting a robust precedent for the company's financial future.
InvestingPro Insights
CorVel Corp's recent stock performance aligns with several key metrics and insights from InvestingPro. The company's strong market position is reflected in its substantial market capitalization of $6.29 billion. CorVel has demonstrated impressive revenue growth, with a 12.66% increase over the last twelve months as of Q2 2025, reaching $845.64 million. This growth trajectory is further emphasized by a quarterly revenue growth of 14.76% in Q2 2025.
InvestingPro Tips highlight CorVel's exceptional performance, noting a "high return over the last year" and that it's "trading near 52-week high." These observations corroborate the article's mention of the stock's 72.97% surge over the past year. Additionally, the company's profitability is underscored by its positive earnings, with a diluted EPS of $4.71 for the last twelve months as of Q2 2025.
Investors should note that CorVel is trading at a high P/E ratio of 75.41, which may indicate high growth expectations. This valuation metric, combined with the InvestingPro Tip that CorVel is "trading at a high earnings multiple," suggests that investors are pricing in continued strong performance.
For readers seeking a more comprehensive analysis, InvestingPro offers 14 additional tips on CorVel, providing a deeper dive into the company's financial health and market position.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.